MARK MENGE NPI 1760469928

NPI Information

  • NPI: 1760469928
  • Provider Name: MARK MENGE
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3800 PARK NICOLLET BLVD
    ST LOUIS PARK, MN
    ZIP 55416
  • Phone: (952) 993-3248

Map and Directions

Get Directions

NPI Details

Mark Menge is a hematology and oncology internal medicine in St Louis Park, MN with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Mark Menge NPI is 1760469928. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Graduation Year:1997

The provider's business location address is:

3800 PARK NICOLLET BLVD
ST LOUIS PARK, MN
ZIP 55416-527
Phone: (952) 993-3248

The NPI 1760469928 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Injection of drug or substance into vein (HCPCS:96374)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 12/29/2005 and was last updated on 10/6/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology42436MINNESOTAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.